Back to Projects
signedINTEGRATE

INTEGRATE - Interdisciplinary Network for Training, Education, and Growing Research into Applications of and Therapeutic Expertise around Psychedelics

Programme: HORIZONScheme: HORIZON-TMA-MSCA-DN
EC Contribution

€4.3M

Duration

01 Mar 202628 Feb 2030

Consortium Size

34

organizations

Objective

Late-stage clinical trials show that psychedelic therapy (PT) has the potential to revolutionize mental disorder treatments, answering a huge and increasing unmet need. INTEGRATE is a multidisciplinary, multi-sectoral Doctoral Network (DN) for training and educating future leaders/experts in implementation of PT in society and healthcare. Four key challenges are identified: 1) The mechanisms of action of PT remain elusive, 2) Lack of clinical gold standards, 3) Legal, financial, and regulatory obstacles for PT access, and 4) Hype, hope, and ethical challenges. Through interdisciplinary research, training, and collaboration, INTEGRATE aims to advance psychedelic science, optimize treatment protocols, and address ethical and regulatory challenges to improve mental healthcare. It addresses the urgent need for well-trained experts to navigate the complex landscape of PT in healthcare. The project will train 16 Doctoral Candidates (DCs) to become T-shaped professionals, equipped with deep disciplinary knowledge and broad interdisciplinary skills. Through collaborative research, innovative training, and strategic secondments, INTEGRATE will tackle the key challenges in PT research with matching research and innovation objectives. The network brings together leading academic institutions, industry partners, and non-profit organizations across Europe, fostering a collaborative environment for advancing psychedelic science and improving mental healthcare.

AI Analysisclaude haiku

Click “Summarize” to get an AI-powered analysis of this project.

Call Topics

HORIZON-MSCA-2024-DN-01-01

Consortium(34 organizations)

OrganizationCountryTypeSMEWebsite

MONASH UNIVERSITY

AUHES

Reconnect Labs AG

CHPRCSME

Schweizerische Ärztegesellschaft für Psycholytische Therapie (SÄPT)

CHREC

UNIVERSITAT BASEL

CHHES

UNIVERSITAT ZURICH

UZH

CHHES

NARODNI USTAV DUSEVNIHO ZDRAVI

NATIONAL INSTITUTE OF MENTAL HEALTH

CZREC

UNIVERZITA KARLOVA

CU

CZHES

CHARITE - UNIVERSITAETSMEDIZIN BERLIN

DEHES

MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV

MPG

DEREC

KOBENHAVNS UNIVERSITET

UCPH

DKHES

ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON

UOA

ELHES

ECOLE DES HAUTES ETUDES EN SCIENCES SOCIALES

EHESS

FRHES

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE

INSERM

FRREC

UNIVERSITE PARIS CITE

UPCité

FRHES

ACADEMISCH ZIEKENHUIS GRONINGEN

UNIVERSITAIR MEDISCH CENTRUM GRONINGEN

NLHES

MIND Landelijke Platform Psychische Gezondheid

NLOTH

RIJKSUNIVERSITEIT GRONINGEN

NLHES

STICHTING CENTRE FOR HUMAN DRUG RESEARCH

CHDR

NLPRCSME

STICHTING OPEN: ONDERZOEK NAAR DE PSYCHEDELISCHE ERVARING NEDERLAND

NLOTH

UNIVERSITEIT LEIDEN

ULEI

NLHES

UNIVERSITEIT MAASTRICHT

NLHES

Avextra Portugal SA

PTPRC

FUNDACAO D. ANNA DE SOMMER CHAMPALIMAUD E DR. CARLOS MONTEZ CHAMPALIMAUD

FUNDACAO CHAMPALIMAUD

PTREC

ISPA CRL

ISPA

PTHES

OSMOND LABS AB

SEPRCSME

STOCKHOLMS UNIVERSITET

SEHES

Svenska kyrkan Solna

SEOTH

UPPSALA UNIVERSITET

UU

SEHES

Clerkenwell Clinics Limited

Clerkenwell Health

UKPRCSME

Simon Geoffrey David Ruffell

ONAYA SCIENCE LIMITED

UKOTH

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD

UOXF

UKHES

THE UNIVERSITY OF EXETER

UNEXE

UKHES

Alithos Health, Inc.

USPRCSME

JOHNS HOPKINS UNIVERSITY

USHES